2.94

20.44% 0.52

Estrella Immunopharma Inc (ESLA)

Overview News Price History Discussions Forecast

Estrella Immunopharma Inc stock is traded at $2.94, with a volume of 845.12K. It is up +20.44% in the last 24 hours and up +122.49% over the past month. Estrella Immunopharma Inc is a clinical-stage biopharmaceutical company developing CD19 and CD22-targeted ARTEMIS T-cell therapies with the capacity to address treatment challenges for patients with blood cancers and solid tumors. Estrella's mission is to harness the evolutionary power of the human immune system to transform the lives of patients fighting cancer and autoimmune diseases.

Previous Close:

$2.42

Open:

$2.43

24h Volume:

845.12K

Relative Volume:

5.07

Market Cap:

$109.34M

Revenue:

Net Income/Loss:

$-8.82M

P/E Ratio:

-9.80

EPS:

-0.3

Net Cash Flow:

$-18.01M

1W Performance:

+27.83%

1M Performance:

+122.49%

6M Performance:

+151.26%

1Y Performance:

+301.46%

1-Day Range:

$2.395

$3.00

1-Week Range:

$2.13

$3.00

52-Week Range:

$0.6951

$3.00

Estrella Immunopharma Inc Stock (ESLA) Company Profile

Name

Estrella Immunopharma Inc

Sector

Healthcare (1139)

Industry

Biotechnology (635)

Phone

(510) 318-9098

Address

5858 HORTON STREET, SUITE 370, EMERYVILLE

Employee

Twitter

Next Earnings Date

Latest SEC Filings

ESLA's Discussions on Twitter

Compare ESLA with other stocks

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
ESLA Estrella Immunopharma Inc	2.95	89.70M	0	-8.82M	-18.01M	-0.30
VRTX Vertex Pharmaceuticals Inc	425.69	109.11B	11.39B	3.64B	3.50B	13.99
REGN Regeneron Pharmaceuticals Inc	641.80	68.50B	14.25B	4.58B	3.88B	41.77
ALNY Alnylam Pharmaceuticals Inc	432.61	60.25B	3.21B	43.57M	221.36M	0.2405
ARGX Argen X Se Adr	822.11	50.39B	3.06B	1.28B	447.35M	19.67
INSM Insmed Inc	183.82	40.44B	447.02M	-1.18B	-868.57M	-6.1812

Estrella Immunopharma Inc Stock (ESLA) Latest News

08:00 AM

Estrella Immunopharma Completes Second Dose Cohort in STARLIGHT-1 Trial of EB103 with Complete Responses in All Evaluable Patients - Business Wire

08:00 AM

07:38 AM

What data driven models say about Estrella Immunopharma Inc.’s future - newser.com

07:38 AM

06:02 AM

Is Estrella Immunopharma Inc. building a consolidation base2025 Market Outlook & AI Forecasted Entry/Exit Points - newser.com

06:02 AM

05:45 AM

Is now a turning point for Estrella Immunopharma Inc.Quarterly Portfolio Summary & Growth-Oriented Investment Plans - newser.com

05:45 AM

04:51 AM

Is Estrella Immunopharma Inc. reversing from oversold territoryQuarterly Profit Summary & Expert Verified Movement Alerts - newser.com

04:51 AM

04:18 AM

How to integrate Estrella Immunopharma Inc. into portfolio analysis tools2025 Year in Review & Fast Exit and Entry Strategy Plans - newser.com

04:18 AM

02:39 AM

What indicators show strength in Estrella Immunopharma Inc.2025 Valuation Update & Daily Chart Pattern Signals - newser.com

02:39 AM

Nov 02, 2025

Is Estrella Immunopharma Inc. stock ready for breakoutTrade Risk Report & Daily Stock Trend Reports - newser.com

Nov 02, 2025

Will Estrella Immunopharma Inc. stock gain from government policiesJuly 2025 Chart Watch & Precise Entry and Exit Recommendations - newser.com

Nov 02, 2025

Using data models to predict Estrella Immunopharma Inc. stock movementShare Buyback & Safe Swing Trade Setups - newser.com

Nov 02, 2025

Nov 01, 2025

Estrella Immunopharma (NASDAQ:ESLA) Earns Sell (D-) Rating from Weiss Ratings - MarketBeat

Nov 01, 2025